Leland Metheny, MD

Showing    of 2 results

UH Seidman Cancer Center Leads $7.3 Million Multi-Site Trial of Relapse Prevention in ALL

Survival at one year post-stem cell transplant is 100% - Innovations in Cancer | Fall 2020

Intraosseous Co-Transplantation Shows Better Engraftment in Stem Cell Transplant

Results of study lead to first-of-its-kind Phase I clinical trial at UH Seidman Cancer Center - Innovations in Cancer | Spring 2017

Results are loading...
Back to Top